| Nome |
# |
|
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study, file e4233f16-d1c2-2860-e053-6605fe0a460a
|
65
|
|
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes., file e4233f14-fddd-2860-e053-6605fe0a460a
|
56
|
|
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach., file e4233f19-6d34-2860-e053-6605fe0a460a
|
42
|
|
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation, file e4233f14-ee73-2860-e053-6605fe0a460a
|
33
|
|
Oxidative stress in chronic vascular disease: From prediction to prevention, file e4233f19-65b0-2860-e053-6605fe0a460a
|
33
|
|
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards, file e4233f16-e868-2860-e053-6605fe0a460a
|
26
|
|
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach., file e4233f19-67c3-2860-e053-6605fe0a460a
|
20
|
|
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach., file e4233f19-5176-2860-e053-6605fe0a460a
|
18
|
|
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes, file e4233f19-517f-2860-e053-6605fe0a460a
|
17
|
|
null, file e4233f17-acbc-2860-e053-6605fe0a460a
|
14
|
|
Oxidative stress in chronic vascular disease: From prediction to prevention, file e4233f19-54a3-2860-e053-6605fe0a460a
|
14
|
|
null, file e4233f16-e7e1-2860-e053-6605fe0a460a
|
11
|
|
Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection., file e4233f15-a288-2860-e053-6605fe0a460a
|
10
|
|
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients, file e4233f16-e2b4-2860-e053-6605fe0a460a
|
10
|
|
Leptin increase is associated with markers of the hemostatic system in obese healthy women, file e4233f14-ef8e-2860-e053-6605fe0a460a
|
9
|
|
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus, file e4233f15-a219-2860-e053-6605fe0a460a
|
9
|
|
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy., file e4233f15-c98e-2860-e053-6605fe0a460a
|
9
|
|
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients, file e4233f19-4302-2860-e053-6605fe0a460a
|
9
|
|
OBESITA': LEPTINA E FATTORI ENDOTELIALI E DELLA COAGULAZIONE (103° congresso nazionale della Società Italiana di Medicina Interna - Milano, 19-22 novembre 2002), file e4233f17-1070-2860-e053-6605fe0a460a
|
8
|
|
Platelets, oxidative stress and preservation of the vascular endothelium: Is it a matter of fat?, file e4233f15-0bdd-2860-e053-6605fe0a460a
|
7
|
|
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation, file e4233f16-e6d2-2860-e053-6605fe0a460a
|
7
|
|
Pentraxin 3 and platelet activation in obese patients after gastric banding, file e4233f15-9e9f-2860-e053-6605fe0a460a
|
6
|
|
Thromboxane-Dependent Platelet Activation After Gastric Banding for Obesity., file 14ce1b37-84b4-4851-aeab-1f5aba640ed4
|
5
|
|
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women, file e4233f14-e9ac-2860-e053-6605fe0a460a
|
5
|
|
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria, file e4233f14-f167-2860-e053-6605fe0a460a
|
5
|
|
Insulin resistance as a determinant of platelet activation in obese women., file e4233f14-f944-2860-e053-6605fe0a460a
|
5
|
|
Platelet activation in obesity and metabolic syndrome., file e4233f14-fa0d-2860-e053-6605fe0a460a
|
5
|
|
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages., file e4233f15-3a15-2860-e053-6605fe0a460a
|
5
|
|
Atherothrombotic disease and the metabolic syndrome., file e4233f15-d4cf-2860-e053-6605fe0a460a
|
5
|
|
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients, file e4233f16-df31-2860-e053-6605fe0a460a
|
5
|
|
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients, file e4233f16-e2b5-2860-e053-6605fe0a460a
|
5
|
|
Platelet activation in obese women: role of inflammation and oxidant stress., file e4233f17-b11e-2860-e053-6605fe0a460a
|
5
|
|
Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients, file e4233f18-7876-2860-e053-6605fe0a460a
|
5
|
|
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study, file e4233f18-c4f9-2860-e053-6605fe0a460a
|
5
|
|
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss., file e4233f14-f22c-2860-e053-6605fe0a460a
|
4
|
|
Obesity-driven inflammation and colorectal cancer, file e4233f15-0820-2860-e053-6605fe0a460a
|
4
|
|
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis, file e4233f16-8475-2860-e053-6605fe0a460a
|
4
|
|
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly, file e4233f16-dcb6-2860-e053-6605fe0a460a
|
4
|
|
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study, file e4233f18-b680-2860-e053-6605fe0a460a
|
4
|
|
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people, file e4233f19-650b-2860-e053-6605fe0a460a
|
4
|
|
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy., file e4233f14-f760-2860-e053-6605fe0a460a
|
3
|
|
Insulin resistance as a determinant of platelet activation in obese women., file e4233f14-f945-2860-e053-6605fe0a460a
|
3
|
|
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress, file e4233f15-0094-2860-e053-6605fe0a460a
|
3
|
|
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism, file e4233f15-03be-2860-e053-6605fe0a460a
|
3
|
|
The left atrial appendage: from embryology to prevention of thromboembolism, file e4233f15-9587-2860-e053-6605fe0a460a
|
3
|
|
CD40/CD40L system and vascular disease., file e4233f15-a222-2860-e053-6605fe0a460a
|
3
|
|
Soluble RAGE in type 2 diabetes: association with oxidative stress., file e4233f15-a223-2860-e053-6605fe0a460a
|
3
|
|
null, file e4233f15-c930-2860-e053-6605fe0a460a
|
3
|
|
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study, file e4233f16-dec8-2860-e053-6605fe0a460a
|
3
|
|
Antipsychotic prescription and mortality in hospitalized older persons, file e4233f16-df33-2860-e053-6605fe0a460a
|
3
|
|
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients, file e4233f16-e222-2860-e053-6605fe0a460a
|
3
|
|
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study, file e4233f16-e330-2860-e053-6605fe0a460a
|
3
|
|
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients, file e4233f16-e384-2860-e053-6605fe0a460a
|
3
|
|
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study, file e4233f16-e55b-2860-e053-6605fe0a460a
|
3
|
|
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register, file e4233f17-0f77-2860-e053-6605fe0a460a
|
3
|
|
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients, file e4233f17-83f3-2860-e053-6605fe0a460a
|
3
|
|
null, file e4233f18-9e9e-2860-e053-6605fe0a460a
|
3
|
|
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction, file e4233f14-ef6d-2860-e053-6605fe0a460a
|
2
|
|
Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control, file e4233f14-f118-2860-e053-6605fe0a460a
|
2
|
|
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis, file e4233f14-f455-2860-e053-6605fe0a460a
|
2
|
|
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus, file e4233f15-53b9-2860-e053-6605fe0a460a
|
2
|
|
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective, file e4233f15-8fd6-2860-e053-6605fe0a460a
|
2
|
|
Coagulation and infective endocarditis: sooner or later, file e4233f15-9417-2860-e053-6605fe0a460a
|
2
|
|
Aspirin for primary prevention in diabetes mellitus: From the calculation of cardiovascular risk and risk/benefit profile to personalised treatment, file e4233f15-98fa-2860-e053-6605fe0a460a
|
2
|
|
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper, file e4233f15-a88d-2860-e053-6605fe0a460a
|
2
|
|
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis., file e4233f15-a88f-2860-e053-6605fe0a460a
|
2
|
|
Italian intersociety consensus on DOAC use in internal medicine, file e4233f15-f308-2860-e053-6605fe0a460a
|
2
|
|
Platelets and Diabetes, file e4233f16-5800-2860-e053-6605fe0a460a
|
2
|
|
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study, file e4233f16-d1c5-2860-e053-6605fe0a460a
|
2
|
|
Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: Results from the REPOSI registry, file e4233f16-da7f-2860-e053-6605fe0a460a
|
2
|
|
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy, file e4233f16-dea5-2860-e053-6605fe0a460a
|
2
|
|
Heart failure and chronic kidney disease in a registry of internal medicine wards, file e4233f16-df63-2860-e053-6605fe0a460a
|
2
|
|
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity., file e4233f16-e0b3-2860-e053-6605fe0a460a
|
2
|
|
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI, file e4233f16-e758-2860-e053-6605fe0a460a
|
2
|
|
Gender difference in drug use in hospitalized elderly patients, file e4233f16-e785-2860-e053-6605fe0a460a
|
2
|
|
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus., file e4233f16-f297-2860-e053-6605fe0a460a
|
2
|
|
Associazione tra livelli ematici di leptina e valori pressori delle 24 ore in donne obese normotese. Poster 303, file e4233f17-0af3-2860-e053-6605fe0a460a
|
2
|
|
null, file e4233f19-703c-2860-e053-6605fe0a460a
|
2
|
|
Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus., file e4233f19-70a3-2860-e053-6605fe0a460a
|
2
|
|
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin, file e4233f14-eff9-2860-e053-6605fe0a460a
|
1
|
|
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance", file e4233f14-f104-2860-e053-6605fe0a460a
|
1
|
|
Determinants of platelet activation in hypertensives with microalbuminuria., file e4233f14-f139-2860-e053-6605fe0a460a
|
1
|
|
Homocysteine modulates the CD40/CD40L system, file e4233f14-f182-2860-e053-6605fe0a460a
|
1
|
|
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response, file e4233f14-f8d0-2860-e053-6605fe0a460a
|
1
|
|
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment., file e4233f14-f942-2860-e053-6605fe0a460a
|
1
|
|
Determinants of increased cardiovascular disease in obesity and metabolic syndrome., file e4233f14-fa0c-2860-e053-6605fe0a460a
|
1
|
|
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus., file e4233f14-fa11-2860-e053-6605fe0a460a
|
1
|
|
Variability in the response to antiplatelet treatment in diabetes mellitus., file e4233f14-fd55-2860-e053-6605fe0a460a
|
1
|
|
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction, file e4233f15-0204-2860-e053-6605fe0a460a
|
1
|
|
Biomarkers of platelet activation in acute coronary syndromes, file e4233f15-081f-2860-e053-6605fe0a460a
|
1
|
|
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis, file e4233f15-0942-2860-e053-6605fe0a460a
|
1
|
|
High serum CXCL10 in Rickettsia conorii infection is endothelial cell mediated subsequent to whole blood activation, file e4233f15-8fbb-2860-e053-6605fe0a460a
|
1
|
|
The Coxib case: Are EP receptors really guilty?, file e4233f15-90da-2860-e053-6605fe0a460a
|
1
|
|
Arterial stiffness and sedentary lifestyle: Role of oxidative stress, file e4233f15-912b-2860-e053-6605fe0a460a
|
1
|
|
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications, file e4233f15-9252-2860-e053-6605fe0a460a
|
1
|
|
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome, file e4233f15-9415-2860-e053-6605fe0a460a
|
1
|
|
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease, file e4233f15-986e-2860-e053-6605fe0a460a
|
1
|
|
Platelets and diabetes mellitus, file e4233f15-98fd-2860-e053-6605fe0a460a
|
1
|
|
Aspirin, platelets, and cancer: The point of view of the internist., file e4233f15-9ea8-2860-e053-6605fe0a460a
|
1
|
|
Aspirin as antiplatelet agent in diabetes. PROS-., file e4233f15-a218-2860-e053-6605fe0a460a
|
1
|
| Totale |
633 |